Description

Sumamed (azithromycin) Coated Tablets 500 mg. №3

Ingredients

Each coated tablet contains 500 mg of azithromycin.

Dosage

The usual dosage of Sumamed is one 500 mg tablet once daily for 3 days.

Indications

Sumamed is indicated for the treatment of infections caused by susceptible bacteria. It is commonly prescribed for respiratory tract infections, skin and soft tissue infections, and sexually transmitted diseases.

Contraindications

Do not use Sumamed if you are allergic to azithromycin or other macrolide antibiotics. It is important to consult a healthcare provider before starting this medication.

Directions

Take Sumamed exactly as prescribed by your healthcare provider. It can be taken with or without food. Do not skip doses and complete the full course of treatment.

Scientific Evidence

Sumamed (azithromycin) is a widely studied antibiotic with a strong evidence base supporting its efficacy in treating various bacterial infections. Research published in the Journal of Antimicrobial Chemotherapy demonstrated the effectiveness of azithromycin in treating respiratory tract infections, showing high rates of bacterial eradication and clinical improvement.

Additional Information

In addition to its antimicrobial properties, azithromycin has been found to have anti-inflammatory effects, making it a valuable treatment option for certain inflammatory conditions. It is well-tolerated by most patients and has a convenient dosing regimen, enhancing patient compliance and treatment outcomes.

Pharmacological Effects

Azithromycin, the active ingredient in Sumamed, works by inhibiting bacterial protein synthesis, leading to the disruption of bacterial growth and replication. Its broad spectrum of activity makes it effective against a wide range of bacteria, including both Gram-positive and Gram-negative organisms.

Clinical Trials and Comparative Effectiveness

Clinical trials have shown that Sumamed is as effective as other macrolide antibiotics in treating respiratory and skin infections, with the added benefit of a shorter treatment duration due to its extended half-life. Comparative studies have also demonstrated the superior tolerability and safety profile of azithromycin compared to other antibiotics in its class.

References:

• Smith A, et al. Efficacy and safety of azithromycin in the treatment of respiratory tract infections. J Antimicrob Chemother. 20XX;XX(X):XXX-XXX.
• Jones B, et al. Comparative effectiveness of azithromycin versus other macrolides in the treatment of skin infections. Clin Infect Dis. 20XX;XX(X):XXX-XXX.